Abstract
4045 Background: Phase I/II studies with single-fraction (25 Gy) stereotactic body radiotherapy (SBRT) for pancreatic ductal adenocarcinoma (PDA) have shown local progression free survival (LPFS) r...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have